150 related articles for article (PubMed ID: 2949897)
1. Natural cytotoxic activity in multiple sclerosis patients: defects in IL-2/interferon gamma-regulatory circuit.
Braakman E; van Tunen A; Meager A; Lucas CJ
Clin Exp Immunol; 1986 Nov; 66(2):285-94. PubMed ID: 2949897
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanism.
Rook AH; Hooks JJ; Quinnan GV; Lane HC; Manischewitz JF; Macher AM; Masur H; Fauci AS; Djeu JY
J Immunol; 1985 Mar; 134(3):1503-7. PubMed ID: 3918102
[TBL] [Abstract][Full Text] [Related]
3. Generation of activated killer (AK) cells by recombinant interleukin 2 (rIL 2) in collaboration with interferon-gamma (IFN-gamma).
Itoh K; Shiiba K; Shimizu Y; Suzuki R; Kumagai K
J Immunol; 1985 May; 134(5):3124-9. PubMed ID: 2984283
[TBL] [Abstract][Full Text] [Related]
4. [T-cell interferon-gamma, tumor necrosis factor-alpha and interleukin-6 receptor binding in patients with multiple sclerosis. Effects of interferon-beta-1b treatment].
Bongioanni P; Romano MR; Boccardi B; Lombardo F; Moscato G; Mosti S; Baldini C; Nuti S; Meucci G; Rossi B
Rev Neurol; 1999 Nov 16-30; 29(10):893-9. PubMed ID: 10637835
[TBL] [Abstract][Full Text] [Related]
5. Regulation of human natural killer cell activity by interferon-gamma: lack of a role in interleukin 2-mediated augmentation.
Sayers TJ; Mason AT; Ortaldo JR
J Immunol; 1986 Mar; 136(6):2176-80. PubMed ID: 3081640
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of IL-18 receptor in cancer patients: its clinical significance.
Kobashi K; Iwagaki H; Yoshino T; Morimoto Y; Kohka H; Kodama M; Nishibori M; Akagi T; Tanaka N
Anticancer Res; 2001; 21(5):3285-93. PubMed ID: 11848485
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of recombinant human interferon-gamma and interleukin 2 on natural killer cell activity of peripheral blood in early human development.
Ueno Y; Miyawaki T; Seki H; Matsuda A; Taga K; Sato H; Taniguchi N
J Immunol; 1985 Jul; 135(1):180-4. PubMed ID: 3923100
[TBL] [Abstract][Full Text] [Related]
8. Antagonistic action of IFN-beta and IFN-gamma on high affinity Fc gamma receptor expression in healthy controls and multiple sclerosis patients.
Van Weyenbergh J; Lipinski P; Abadie A; Chabas D; Blank U; Liblau R; Wietzerbin J
J Immunol; 1998 Aug; 161(3):1568-74. PubMed ID: 9686625
[TBL] [Abstract][Full Text] [Related]
9. T cell lymphokine-induced secretion of cytokines by monocytes from patients with multiple sclerosis.
Maimone D; Reder AT; Gregory S
Cell Immunol; 1993 Jan; 146(1):96-106. PubMed ID: 8425234
[TBL] [Abstract][Full Text] [Related]
10. Regulation of IFN-gamma induction in human peripheral blood cells by exogenous and endogenously produced interleukin 2.
Vilcek J; Henriksen-Destefano D; Siegel D; Klion A; Robb RJ; Le J
J Immunol; 1985 Sep; 135(3):1851-6. PubMed ID: 3926889
[TBL] [Abstract][Full Text] [Related]
11. Response to and production of interleukin 2 by peripheral blood and cerebrospinal fluid lymphocytes of patients with multiple sclerosis.
Merrill JE; Mohlstrom C; Uittenbogaart C; Kermaniarab V; Ellison GW; Myers LW
J Immunol; 1984 Oct; 133(4):1931-7. PubMed ID: 6088630
[TBL] [Abstract][Full Text] [Related]
12. Defective production of anti-inflammatory cytokine, TGF-beta by T cell lines of patients with active multiple sclerosis.
Mokhtarian F; Shi Y; Shirazian D; Morgante L; Miller A; Grob D
J Immunol; 1994 Jun; 152(12):6003-10. PubMed ID: 8207225
[TBL] [Abstract][Full Text] [Related]
13. Role of IL-2 and interferon in the generation of natural cytotoxic activity in influenza virus-stimulated PBL cultures: analysis with the use of prednisolone.
Braakman E; Treep-van Leeuwen P; ten Berge RJ; Schellekens PT; Lucas CJ
Clin Exp Immunol; 1988 Feb; 71(2):302-7. PubMed ID: 3127093
[TBL] [Abstract][Full Text] [Related]
14. Interferon-beta and recombinant IL 2 can both enhance, but by different pathways, the nonspecific cytolytic potential of T3- natural killer cell-derived clones rather than that of T3+ clones.
van de Griend RJ; Ronteltap CP; Gravekamp C; Monnikendam D; Bolhuis RL
J Immunol; 1986 Mar; 136(5):1700-7. PubMed ID: 3005399
[TBL] [Abstract][Full Text] [Related]
15. [Cytokine-secreting cells in relapsing multiple sclerosis patients treated with high-dose intravenous methylprednisolone].
Yagi Y; Takahashi M; Nakamura Y
Rinsho Shinkeigaku; 1997 Jul; 37(7):575-9. PubMed ID: 9396353
[TBL] [Abstract][Full Text] [Related]
16. Immunological parameters in multiple sclerosis patients with special reference to the herpes virus group.
Haahr S; Møller-Larsen A; Pedersen E
Clin Exp Immunol; 1983 Feb; 51(2):197-206. PubMed ID: 6188564
[TBL] [Abstract][Full Text] [Related]
17. [Interferon production and natural killer activity of peripheral blood lymphocytes obtained from patients with multiple sclerosis].
Maruo Y
Hokkaido Igaku Zasshi; 1988 Jul; 63(4):521-33. PubMed ID: 2464533
[TBL] [Abstract][Full Text] [Related]
18. [Interferon-producing and cytotoxic activity of natural killer cells in multiple sclerosis patients].
Sorokin AM; Koval'chuk LV; Tunkel' OI; Cheknev SB
Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(2):211-5. PubMed ID: 2437743
[TBL] [Abstract][Full Text] [Related]
19. Defective NK cell activity following thermal injury.
Klimpel GR; Herndon DN; Fons M; Albrecht T; Asuncion MT; Chin R; Stein MD
Clin Exp Immunol; 1986 Nov; 66(2):384-92. PubMed ID: 3493101
[TBL] [Abstract][Full Text] [Related]
20. Cellular and molecular mechanisms of the IL-12-induced increase in allospecific murine cytolytic T cell activity. Implications for the age-related decline in CTL.
Bloom ET; Horvath JA
J Immunol; 1994 May; 152(9):4242-54. PubMed ID: 7908914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
